Nigeria’s University of Benin unveils ‘cure’ for HIV/AIDS

A cure for
Human
Immunodeficiency
Virus,HIV,
and
Acquired
Immunodeficiency
Syndrome, AIDS, has been
discovered, a Professor at the
University of Benin said on Tuesday.
Isaiah Ibeh, the Dean of the School of
Basic Medical Science of the
University, said inBenin that the
herbal drug has undergone “series
of successful tests”.
“We are at the threshold of making
history, in the sense that we seem to
have with us something that will
permanently take care of what over
time seems to have defied all
solutions.
“We are talking about
the latest discovery of an oral drug
made from plants extraction in
Nigeria for the possible cure of the
pandemic, HIV and AIDS virus,” he
said.
Mr. Ibeh said research on the project
started in 2010 and culminated in
the development of “Deconcotion X
(DX)–Liquid or Bioclean 11 for the
cure of HIV and AIDS”.
He said that while the existing
retroviral drugs are intervention
drugs for the management of AIDS,
the new discovery is a possible cure.
“We have tried to look at the product
first; its toxicological analysis and
discovered that it has a large safety
margin. This means that if animals
or human beings are exposed to it,
they will not suffer any serious harm
at all from the exposure.
“It also helped us to know the
quantity we can conveniently give to
animals and will feel secure that
nothing untoward will happen. We
have also done the bacteriological
analysis on it, after which we looked
at its effect on the virus and the
result was quite revealing and
refreshing.”
Mr. Ibeh also said that the drug had
been exposed to series of
medical examination both in Nigeria
and in the USA.
He added that the drug had
performed well on patients with
the HIV virus and had shown
evidence of total restoration of
damaged tissues.
“The result showed an increase in
the body weight of the individual
administered with DX,” he said. “The
body weight was statistically
significant when compared with the
control group.”
He said that further tests were being
conducted to determine the point at
which “a patient becomes negative
after being administered the drug?”
“This verification is necessary
because it is what is used to
measure whether infection is still
there or not. So we need to know the
siro-convention time.
“But preliminary results showed that
of the five latest patients orally
administered with the drugs, our
findings is that up to seven months ,
three of them were siro negative
while two were sill faintly positive,”
he said.
Mr. Ibeh appealed for support from
the Federal Government and
relevant bodies to assist the
university with relevant equipment
to sustain the research.
NAN